Kiniksa Pharmaceuticals
KNSA
#4667
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
48.08%
Change (1 year)
Categories
EPS for Kiniksa Pharmaceuticals (KNSA)
EPS in 2023 (TTM): -$0.11
According to Kiniksa Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.11. In 2022 the company made an earnings per share (EPS) of $2.64 an increase over its 2021 EPS that were of -$2.30.
EPS history for Kiniksa Pharmaceuticals from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.11 | -104.17% |
| 2022 | $2.64 | -214.78% |
| 2021 | -$2.30 | -10.85% |
| 2020 | -$2.58 | -14.57% |
| 2019 | -$3.02 | 6.33% |
| 2018 | -$2.84 | 42.15% |
| 2017 | -$2.00 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 1,881.82% | 🇺🇸 USA |